![Higher Risk, Higher Reward? Self‐Reported Effects of Real‐World Cannabis Use in Parkinson's Disease - Holden - 2022 - Movement Disorders Clinical Practice - Wiley Online Library Higher Risk, Higher Reward? Self‐Reported Effects of Real‐World Cannabis Use in Parkinson's Disease - Holden - 2022 - Movement Disorders Clinical Practice - Wiley Online Library](https://movementdisorders.onlinelibrary.wiley.com/cms/asset/18d389c7-4e97-4069-a084-266aff22b1f3/mdc313414-fig-0002-m.jpg)
Higher Risk, Higher Reward? Self‐Reported Effects of Real‐World Cannabis Use in Parkinson's Disease - Holden - 2022 - Movement Disorders Clinical Practice - Wiley Online Library
![The pharmacokinetics and the pharmacodynamics of cannabinoids - Lucas - 2018 - British Journal of Clinical Pharmacology - Wiley Online Library The pharmacokinetics and the pharmacodynamics of cannabinoids - Lucas - 2018 - British Journal of Clinical Pharmacology - Wiley Online Library](https://bpspubs.onlinelibrary.wiley.com/cms/asset/62d53021-71ca-41ba-86f4-922bfc8a2742/bcp13710-toc-0001-m.jpg)
The pharmacokinetics and the pharmacodynamics of cannabinoids - Lucas - 2018 - British Journal of Clinical Pharmacology - Wiley Online Library
![Frontiers | Cannabidiol as a Therapeutic Target: Evidence of its Neuroprotective and Neuromodulatory Function in Parkinson's Disease Frontiers | Cannabidiol as a Therapeutic Target: Evidence of its Neuroprotective and Neuromodulatory Function in Parkinson's Disease](https://www.frontiersin.org/files/Articles/595635/fphar-11-595635-HTML/image_m/fphar-11-595635-g007.jpg)